BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mattonen SA, Ward AD, Palma DA. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? Br J Radiol 2016;89:20160113. [PMID: 27245137 DOI: 10.1259/bjr.20160113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Ratnakumaran R, McDonald F. The Management of Oligometastases in Non-small Cell Lung Cancer - is Stereotactic Ablative Radiotherapy now Standard of Care? Clin Oncol (R Coll Radiol) 2022:S0936-6555(22)00378-8. [PMID: 36117126 DOI: 10.1016/j.clon.2022.08.033] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Castorina P, Ferini G, Martorana E, Forte S. Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description. JPM 2022;12:530. [DOI: 10.3390/jpm12040530] [Reference Citation Analysis]
3 Rodler S, Götz M, Mumm JN, Buchner A, Graser A, Casuscelli J, Stief C, Fürweger C, Muacevic A, Staehler M. Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis. Cancers (Basel) 2022;14:356. [PMID: 35053519 DOI: 10.3390/cancers14020356] [Reference Citation Analysis]
4 Tjong MC, Louie AV, Iyengar P, Solomon BJ, Palma DA, Siva S. Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative review. Transl Lung Cancer Res 2021;10:3446-56. [PMID: 34430379 DOI: 10.21037/tlcr-20-994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Avanzo M, Gagliardi V, Stancanello J, Blanck O, Pirrone G, El Naqa I, Revelant A, Sartor G. Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy. Med Phys 2021;48:6257-69. [PMID: 34415574 DOI: 10.1002/mp.15178] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
6 Piñeiro-Fiel M, Moscoso A, Pubul V, Ruibal Á, Silva-Rodríguez J, Aguiar P. A Systematic Review of PET Textural Analysis and Radiomics in Cancer. Diagnostics (Basel) 2021;11:380. [PMID: 33672285 DOI: 10.3390/diagnostics11020380] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kidane B, Spicer J, Kim JO, Fiset PO, Abdulkarim B, Malthaner R, Palma D. SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic. Front Oncol. 2020;10:580189. [PMID: 33072612 DOI: 10.3389/fonc.2020.580189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
8 Tan D, Gill S, Loh N. Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy. Cancer Med 2020;9:7469-76. [PMID: 32846054 DOI: 10.1002/cam4.3302] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Sun X, Li Y, Zhu Y, Li Q, Yuan X, Lin Q, Weng D, Xu Q, Liu H, Xu Y. Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer. Transl Lung Cancer Res 2020;9:1472-82. [PMID: 32953519 DOI: 10.21037/tlcr-20-851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chassagnon G, Martini K, Giraud P, Revel MP. Radiological assessment after stereotactic body radiation of lung tumours. Cancer Radiother 2020;24:379-87. [PMID: 32534799 DOI: 10.1016/j.canrad.2020.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Frerker B, Hildebrandt G. Distinguishing Radiation Pneumonitis from Local Tumour Recurrence Following SBRT for Lung Cancer

]]>. RMI 2020;Volume 13:1-23. [DOI: 10.2147/rmi.s176901] [Reference Citation Analysis]
12 Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol. 2019;37:1316-1325. [PMID: 30943123 DOI: 10.1200/jco.18.00622] [Cited by in Crossref: 104] [Cited by in F6Publishing: 163] [Article Influence: 34.7] [Reference Citation Analysis]
13 Shi L, He Y, Yuan Z, Benedict S, Valicenti R, Qiu J, Rong Y. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer. Technol Cancer Res Treat 2018;17:1533033818782788. [PMID: 29940810 DOI: 10.1177/1533033818782788] [Cited by in Crossref: 30] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
14 Hasan S, Colonias A, Mickus T, VanDeusen M, Wegner RE. Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experience. Thorac Cancer 2018;9:699-706. [PMID: 29697204 DOI: 10.1111/1759-7714.12635] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nguyen TK, Senan S, Bradley JD, Franks K, Giuliani M, Guckenberger M, Landis M, Loo BW, Louie AV, Onishi H, Schmidt H, Timmerman R, Videtic GM, Palma DA. Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study. Practical Radiation Oncology 2018;8:e71-8. [DOI: 10.1016/j.prro.2017.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
16 Arcangeli S, Falcinelli L, Bracci S, Greco A, Monaco A, Dognini J, Chiostrini C, Bellavita R, Aristei C, Donato V. Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours. Br J Radiol. 2017;90:20160853. [PMID: 28256158 DOI: 10.1259/bjr.20160853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Scalco E, Rizzo G. Texture analysis of medical images for radiotherapy applications. Br J Radiol 2017;90:20160642. [PMID: 27885836 DOI: 10.1259/bjr.20160642] [Cited by in Crossref: 59] [Cited by in F6Publishing: 68] [Article Influence: 9.8] [Reference Citation Analysis]
18 Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2016;96:1011-20. [PMID: 27869080 DOI: 10.1016/j.ijrobp.2016.08.033] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]